Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00719147 · ClinicalTrials.gov registry record

AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone

A clinical trial, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
170
Enrollment target

NCT00719147: Completed study, sponsored by St. Jude Children's Research Hospital.

NCT00719147 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 170 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00719147 has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
170 participants
Enrollment target

Study Summary

The primary purpose of this study is to compare the incidence of AVN in children with hematologic malignancies treated with prednisone versus dexamethasone during continuation.

Interventions

  • PROCEDURE MRI
  • OTHER Functional Status and Symptom Questionnaire

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2001-07
Est. Completion 2005-07

What the finished NCT00719147 record still lists

NCT00719147 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.

NCT00719147 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00719147 about?

NCT00719147 is a clinical study titled "AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone". The primary purpose of this study is to compare the incidence of AVN in children with hematologic malignancies treated with prednisone versus dexamethasone during continuation.

What is the current status of trial NCT00719147?

This trial is currently completed. The enrollment target is 170 participants. The study started on 2001-07. Estimated completion is 2005-07.

What interventions are being tested in trial NCT00719147?

The interventions under investigation include: MRI (PROCEDURE), Functional Status and Symptom Questionnaire (OTHER).

Who is sponsoring clinical trial NCT00719147?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02016430 · 170 participants · NA

    Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

  • NCT02621021 · 170 participants · Phase 2

    A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

  • NCT04094701 · 170 participants · NA

    Hip Arthroscopy Postoperative Opioid Demands

  • NCT04166409 · 170 participants · Phase 3

    A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00719147, the US trial registry maintained by the National Library of Medicine. NCT00719147 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.